- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.01. | Title21 Health Solutions Acquires MyCellHub and Its MES Platform | ||
| 06.01. | Autolus Therapeutics Explores the Feasibility of Adopting Cellares' Cell Shuttle Platform | ||
| 06.01. | Alloy Therapeutics Taps Christian Cobaugh as CEO of Genetic Medicines Division | ||
| 06.01. | Kincell Bio Promotes Lawrence Pitcher to CEO | ||
| 05.01. | Daiichi Plans to Invest $1.9B in Production Facilities | ||
| 05.01. | Fujifilm Irvine Scientific Becomes Fujifilm Biosciences | ||
| 05.01. | Skye Bioscience Licenses Halozyme's ENHANZE Drug Delivery Technology | ||
| 02.01. | Emmaus Enters License and Exclusive Distribution Agreement with NeoImmuneTech | ||
| 02.01. | Evotec Names Dr. Sarah Fakih as EVP, Head of Global Communications & Investor Relations | ||
| 02.01. | Harbour BioMed, Lannacheng Partner to Advance Next-Gen RDCs | ||
| 02.01. | Hoth Therapeutics Files New Patents to Expand Oncology Dermatology Platform | ||
| 29.12.25 | Akari Initiates Manufacturing Activities to Support AKTX-101 Development | ||
| 29.12.25 | EirGenix Licenses Transcenta's HiCB Platform to Improve Process Efficiency | ||
| 29.12.25 | Senhwa Aims to Enter Global ADC Market with Combination Cancer Therapy | ||
| 29.12.25 | Novo Nordisk's Wegovy Pill Wins U.S. Approval | ||
| 29.12.25 | BioMarin to Acquire Amicus Therapeutics for $4.8B | ||
| 23.12.25 | Samsung Bioepis' Stelara Biosimilar Approved in Japan | ||
| 22.12.25 | 9 Pharmaceutical Companies Enter Agreement with Trump to Lower Medicine Costs | ||
| 22.12.25 | Symbiosis Begins Commercial Manufacturing at Stirling, UK Facility | ||
| 22.12.25 | Rectify Pharmaceuticals, Boehringer Ingelheim Partner to Accelerate Treatments for CKD | ||
| 18.12.25 | Chitose, Fujifilm Biosciences Partner to Advance Biopharmaceutical Manufacturing | ||
| 18.12.25 | Gilead Sciences Appoints Keeley Wettan as EVP, General Counsel, Legal & Compliance | ||
| 17.12.25 | Galux, Boehringer Ingelheim to Jointly Explore AI in Precision Protein Design | ||
| 17.12.25 | Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies | ||
| 17.12.25 | FDA Approves Exdensur for Severe Asthma |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.